Bayer fights Chagas disease in Argentina together with Caritas: NAPSR News

WASHINGTON - Sept. 19, 2013 - PRLog -- The Bayer Cares Foundation and Caritas Argentina have laid the foundation for a new project to combat the Chagas disease in Argentina. Chagas disease is still an indication with a high unmet medical need because the minor, flu-like symptoms are rather non-specific and therefore often misinterpreted. The collaboration's aims over the next four years are to educate people about Chagas disease, improve early diagnosis in rural areas of Argentina, and make the population more aware of ways in which they can protect themselves. The Bayer Foundation will fund the implementation of the project with donations of EUR 665,000 spread over four years.

Chagas is an infectious disease that affects approximately 10 million people, mainly in the rural areas of South America. The pathogen is a single-celled parasite called Trypanosoma cruzi, which is transmitted by assassin bugs. The disease is often fatal if left untreated, but it can be cured by timely treatment during the acute stage.

Under the project, Caritas and Bayer staff will visit schools in rural areas, which are often cut off from healthcare services, to provide comprehensive and age-appropriate, on-the-spot education about Chagas disease. They will focus on using playful methods to teach the school children. They represent a particularly vulnerable risk group who can also pass on what they learn to their families. To increase the people's knowledge about how the disease spreads, blood tests for diagnosing people infected with the disease will also be conducted, especially in remote areas. A project office in Buenos Aires will pool the findings and, in close collaboration with the public health authorities, subject the data to further analysis and use it to develop preventive measures.

CANDIDATES WHO WANT TO BREAK INTO PHARMACEUTICAL SALES!- Upon successful completion of the training each student will receive the Certification Mark of the CNPR®. The CNPR® represents a level of industry achievement and a demonstrated knowledge of pharmacology, medical terminology, pharmaceutical selling guidelines, physician selling techniques and industry standards. Pharmaceutical sales candidates who have this training will differentiate themselves from other individuals looking for open positions. CNPR® graduates should immediately utilize the NAPSRx® Career Center to apply for pharmaceutical sales positions.

The CNPR is a federally trademarked certification you can earn by demonstrating the necessary knowledge in pharmacology, medical terminology, physiology, and regulations for selling pharmaceuticals. The CNPR examination is dedicated to increasing the professional level of NAPSR members and to developing meaningful and ethical standards fully accepted by both its members and members of the pharmaceutical community.

Individuals that are interested in becoming a Certified National Pharmaceutical Representative(CNPR) can contact the National Association of Pharmaceutical Sales Representatives(NAPSRx) for more information.

800-284-1060
www.napsronline.com